| Lewisboro Physical Therapy Pc | |
|
890 Route 35, Cross River, NY 10518 | |
| (914) 763-5941 | |
| (914) 763-5332 |
| Full Name | Lewisboro Physical Therapy Pc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 890 Route 35, Cross River, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316006216 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Sean W Waters |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1528157385 PECOS PAC ID: 4284679176 Enrollment ID: I20050627001238 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.
Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).
After months of negotiation, haggling, posturing and talking, the Senate Finance Committee votes today on a health care reform bill.
Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
| Provider Name | Michael J Sweeney |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073000600 PECOS PAC ID: 0345268082 Enrollment ID: I20051110000617 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.
Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).
After months of negotiation, haggling, posturing and talking, the Senate Finance Committee votes today on a health care reform bill.
Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
| Provider Name | Luanne Sforza |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1053580522 PECOS PAC ID: 9436237070 Enrollment ID: I20080512000598 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.
Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).
After months of negotiation, haggling, posturing and talking, the Senate Finance Committee votes today on a health care reform bill.
Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
| Provider Name | Natalia R Glenn |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1013086131 PECOS PAC ID: 2668657255 Enrollment ID: I20110824000276 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.
Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).
After months of negotiation, haggling, posturing and talking, the Senate Finance Committee votes today on a health care reform bill.
Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
| Provider Name | Dariusz Jarzabkowski |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1992046973 PECOS PAC ID: 7517190754 Enrollment ID: I20140424000069 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.
Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).
After months of negotiation, haggling, posturing and talking, the Senate Finance Committee votes today on a health care reform bill.
Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lewisboro Physical Therapy Pc 990 Peachtree Ind Blvd Box 101, Suwanee, GA 30024-5257 Ph: (833) 888-7868 | Lewisboro Physical Therapy Pc 890 Route 35, Cross River, NY 10518 Ph: (914) 763-5941 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.
Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).
After months of negotiation, haggling, posturing and talking, the Senate Finance Committee votes today on a health care reform bill.
Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
Michael John Sweeney, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 | |
Johanna Lubbe Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 892 Ny-35, Cross River, NY 10518 Phone: 914-875-9430 | |
Mrs. Anna M Mercer, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 | |
Johanna Lubbe, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 892 Route 35, Cross River, NY 10518 Phone: 914-875-9430 Fax: 914-875-9435 | |
Physical Therapy Of Lewisboro Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 | |
Ms. Debra S Cipriani, MS ED PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 890 Route 35, Cross River, NY 10518 Phone: 914-763-5941 Fax: 914-763-5332 |